Menu
Back to User profile » Dr Matthias Trampisch
Papers published by Dr Matthias Trampisch:
Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD
Andreas S, McGarvey L, Bothner U, Trampisch M, de la Hoz A, Fležar M, Buhl R, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1935-1944
Published Date: 10 August 2020
No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1945-1953
Published Date: 10 August 2020
A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1955-1965
Published Date: 10 August 2020
Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1819-1831
Published Date: 1 June 2018
Nicoboxil/nonivamide cream effectively and safely reduces acute nonspecific low back pain – a randomized, placebo-controlled trial
Blahova Z, Holm JC, Weiser T, Richter E, Trampisch M, Akarachkova E
Journal of Pain Research 2016, 9:1221-1230
Published Date: 14 December 2016